Research Antibodies & Reagents Market by Product, Technology, Indication, Application, End User

Description

List of Tables

[197 Pages Report] The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030.

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 16.54 billion
Estimated Year [2024]	USD 18.55 billion
Forecast Year [2030]	USD 36.62 billion
CAGR (%)	12.02%

Product: Increasing popularity of antibodies for detection and quantification of target proteins

Antibodies, specialist proteins that detect foreign bodies such as bacteria and viruses, are fundamental in several immunoassay applications such as western blotting and flow cytometry. There are different types, such as monoclonal antibodies (mAbs), which are identical because they are produced by a kind of immune cell, all clones of a single parent cell, ensuring uniformity and high specificity. Polyclonal antibodies (pAbs) are derived from different B cell lines, resulting in a mixture of antibodies that identify distinct epitopes on the same antigen. Recombinant antibodies are derived from a broad mix of parental antibodies and are usually engineered to have a desired specificity. Reagents are crucial for biochemical assays, genetic processing, and other molecular biology techniques. The reagents group includes many elements, such as buffers, which are responsible for maintaining the pH of a solution, making them vital for many biological processes. Enzymes, proteins that speed up chemical reactions, are instrumental in breaking down, combining, or changing certain chemicals in the body. Fixatives preserve tissues from decay, which is beneficial in histology and pathology labs. Media & sera refer to the sustenance provided to cells under cell culture; the 'media' offer essential nutrients while 'sera' provide additional growth factors that help cells multiply. Probes are utilized predominantly in molecular biology and biochemistry to detect, identify, and isolate specific sequences in DNA or RNA. Solvents are substances, usually a liquid, used to dissolve a solute, resulting in a solution. Stains & dyes are chemicals used to enhance the contrast in the microscopic image or to make a microscopic image visible for observation. While both product segments occupy an essential position in the research context, they cater to different research needs. Antibodies lend themselves to the detection and quantification of target proteins, while reagents facilitate broader laboratory techniques, including DNA, RNA manipulation, biochemical reactions, and cell cultures.

Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping

Enzyme-linked Immunosorbent Assay (ELISA) is a procedure for quantifying and detecting specific antigens or antibodies in biological samples. ELISA is an advantageous technology due to its high sensitivity, specificity, and low cost, which suits research, diagnostic, and quality control applications in various fields, such as infectious disease testing and drug monitoring. Flow cytometry is a laser-based technology that permits concurrent measurement of multiple parameters on individual cells in a fast and efficient manner. It is commonly used for cell counting, sorting, immunophenotyping, and biomarker detection in immunology, oncology, hematology, and stem cell research. Immunofluorescence is a microscopy-based technique that uses fluorescently labeled antibodies to detect specific proteins or other biomolecules in cells and tissues. It offers high sensitivity, specificity, and spatial resolution for studying protein expression, localization, and interaction in fixed or live samples. Immunohistochemistry is an essential method for localizing proteins within tissue sections using specific antibodies conjugated with chromogenic or fluorescent markers. IHC is widely used in pathological diagnosis, research on cellular processes, and drug discovery efforts. Immunoprecipitation is a powerful method used to isolate target proteins from complex mixtures by using specific antibodies immobilized on solid support beads. IP can help study protein-protein interactions, post-translational modifications, and protein-nucleic acid interactions. Western blotting is a technique for catching specific proteins in complex samples based on their molecular weight using gel electrophoresis followed by antibody-based detection on membranes. It serves as a tool for protein expression analysis, validation of gene silencing or overexpression experiments, and diagnostic evaluations.

Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases

Immunology-based antibodies and reagents are paramount in allergy and asthma, autoimmune disease, and transplantation. In fighting infectious diseases, research antibodies are key tools in the identification and detection of pathogens by utilizing research antibodies to demonstrate the presence of specific antigens or antibodies in a patient's serum. Additionally, reagents are vital in cultivating viruses for vaccines and antiviral drug testing. Neurobiology needs antibodies and reagents, with research focusing on neurodegenerative diseases and brain injuries. Research antibodies have revolutionized the field of oncology and are widely employed in the targeted therapy of cancer, where monoclonal antibodies can bind to cancer cells, hindering their growth and proliferation. Their utility in immunohistochemistry allows for the detailed subtype classification of tumors. In the area of stem cell research, antibodies play an indispensable role in the determination of stem cell potency and differentiation status. Reagents are heavily used in cell culture to help the growth and differentiation of stem cells. Stem cell research has seen steady advancements in regenerative medicine and therapeutic cloning, largely fueled by the evolving applications of research antibodies and reagents.

Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets

In drug development, research antibodies and reagents are crucial in target identification, validation, and pre-clinical studies. They facilitate the identification of protein targets, accelerate therapeutic antibody generation, and support the evaluation of drug efficacy and safety. Genomics research relies on high-quality antibodies and reagents for techniques such as gene expression analysis, chromatin immunoprecipitation (ChIP), DNA methylation studies, and CRISPR/Cas9 gene editing. These tools help identify genes involved in diseases and enable a deeper understanding of genetic mechanisms. In proteomics research, antibodies are indispensable tools for protein detection and quantification through methods such as western blotting, enzyme-linked immunosorbent assay (ELISA), mass spectrometry (MS), or protein microarrays. High-performance research antibodies enable investigators to study post-translational modifications (PTMs), protein-protein interactions (PPIs), and cellular localization of proteins accurately. Research antibodies and reagents remain indispensable tools within life science applications driven by ongoing innovations in synthetic biology or CRISPR/Cas9 gene editing techniques. These advancements continue to shape our understanding of biology and disease mechanisms with unprecedented precision.

End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies

Academic & research institutions predominantly require antibodies & reagents for various types of biomedical and clinical research. Entities such as universities, medical schools, and governed research institutes prefer comprehensive kits and highly specific antibodies to facilitate research in immunology, cell biology, molecular biology, and biochemistry. Contract research organizations (CROs) increasingly use antibodies & reagents in their pre-clinical and clinical research. Primarily, CROs focus on high sensitivity and reliability in their assays and prefer reagents that optimize the efficiency of high-throughput screening. Pharmaceutical and biotechnology companies utilize antibodies and reagents extensively in drug development and therapeutic interventions.

Regional Insights

Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies & Reagents Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies & Reagents Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Alpha Teknova, Inc., Atlas Antibodies AB, Avantor, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux S.A., Cardinal Health, Inc., Cell Signaling Technology, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dovetail Genomics LLC, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GenScript Biotech Corporation, Honeywell International Inc., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Leinco Technologies, Inc., LifeSpan BioSciences, Inc., LobaChemie Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Antibodies
  - Monoclonal Antibodies
  - Polyclonal Antibodies
  - Recombinant Antibodies

Reagent
- Buffers
- Enzymes
- Fixatives
- Media & Sera
- Probes
- Solvents
- Stains & Dyes

Technology
- Enzyme-linked Immunosorbent Assay
- Flow Cytometry
- Immunofluorescence
- Immunohistochemistry
- Immunoprecipitation
- Western Blotting

Indication
- Immunology
- Infectious Diseases
- Neurobiology
- Oncology
- Stem Cells

Application
- Drug Development
- Genomics
- Proteomics

End User
- Academic & Research Institutions
- Contract Research Organizations
- Pharmaceutical & Biotechnology

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Research Antibodies & Reagents Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies & Reagents Market?

3. What are the technology trends and regulatory frameworks in the Research Antibodies & Reagents Market?

4. What is the market share of the leading vendors in the Research Antibodies & Reagents Market?

5. Which modes and strategic moves are suitable for entering the Research Antibodies & Reagents Market?

Product Code: MRR-0D217D5AE090

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
  - 5.1.1.2. Rising popularity of proteomics and genomics research
  - 5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
- 5.1.2. Restraints
  - 5.1.2.1. High cost of antibody development processes
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing R&D in research antibodies & reagents
  - 5.1.3.2. Rising focus on discovering novel biomarkers
- 5.1.4. Challenges
  - 5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
- 5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
- 5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
- 5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
- 5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
5.3. Market Trend Analysis
- 5.3.1. Increasing government investment for drug discovery coupled with robust foothold of major companies in Americas region
- 5.3.2. Improving healthcare infrastructure and rising investment in life sciences research in the Asia-Pacific region
- 5.3.3. Expanding government support for research and development in the field of genomics and strong foothold of major biotechnology companies in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis

6. Research Antibodies & Reagents Market, by Product

6.1. Introduction
6.2. Antibodies
6.3. Reagent

7. Research Antibodies & Reagents Market, by Technology

7.1. Introduction
7.2. Enzyme-linked Immunosorbent Assay
7.3. Flow Cytometry
7.4. Immunofluorescence
7.5. Immunohistochemistry
7.6. Immunoprecipitation
7.7. Western Blotting

8. Research Antibodies & Reagents Market, by Indication

8.1. Introduction
8.2. Immunology
8.3. Infectious Diseases
8.4. Neurobiology
8.5. Oncology
8.6. Stem Cells

9. Research Antibodies & Reagents Market, by Application

9.1. Introduction
9.2. Drug Development
9.3. Genomics
9.4. Proteomics

10. Research Antibodies & Reagents Market, by End User

10.1. Introduction
10.2. Academic & Research Institutions
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology

11. Americas Research Antibodies & Reagents Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Research Antibodies & Reagents Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Research Antibodies & Reagents Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
- 14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
- 14.3.3. Danaher to Acquire Abcam plc
- 14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
- 14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
- 14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
- 14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
- 14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
- 14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
- 14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio